MedTrace Logo

High-Dose Quinapril Versus Low-Dose Quinapril Plus Amlodipine in the Treatment of High-Risk Hypertensive Patients

NCT00313547 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2008-05-06

No results posted yet for this study

Summary

The purpose of this study is to compare the impact of two blood pressure lowering treatments (high dose quinapril versus low dose quinapril plus amlodipine) on variations in heart rate over 24 hours.

Conditions

Interventions

DRUG

Quinapril 40 mg

DRUG

Quinapril 10 mg and amlodipine 5 mg

Sponsors & Collaborators

  • Pfizer

    collaborator INDUSTRY

  • Montreal Heart Institute

    lead OTHER

Principal Investigators

  • Michel White, MD · Montreal Heart Institute

  • Simon de Denus, B. Pharm, MSc · Faculty of Pharmacy, University of Montreal/Montreal Heart Institute

  • Jacques de Champlain, MD, PhD · Faculty of Medicine, University of Montreal

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-04-30
Primary Completion
2007-04-30
Completion
2008-03-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00313547 on ClinicalTrials.gov